Journal of labelled compounds and radiopharmaceuticals p. 965 - 975 (1998)
Update date:2022-08-03
Topics:
Moreau
Labarre
Foucaud
Seguin
Bayle
Papon
Madelmont
N-(4-dipropylaminobutyl)-4-iodobenzamide was recently developed in our laboratory as a potentially improved imaging agent for metastatic melanoma. Our purpose was to seek an efficient route to the labelling of this tracer with iodine-125 at a carrier free
View MoreContact:+86-27-67841589
Address:Add: 999 Gaoxin Road, Donghu New Technology Development Zone, Wuhan City, Hubei, China
Contact:
Address:308# dongwu avenue dongxihu district wuhan city
Suzhou SuKaiLu Chemical Technology Co., Ltd.
Contact:+86-512-62766020
Address:Floor 4, Building 1, Xinyi Pharmaceutical Valley Wisdom Industrial Park, 415 Changyang Street, Suzhou Industrial Park, Jiangsu Province
Zhejiang Tianyu Pharmaceutical Co., Ltd.
Contact:+86-576-84177669, 89189665,89189688,84168770
Address:Jiangkou Development Zone, Huangyan, Taizhou City, Zhejiang
Chemsigma International Co.,Ltd.
website:http://www.chemsigma.com
Contact:86-025-58748998
Address:Rm.705, 15th Building,Rd.Xinke II
Doi:10.1139/v02-096
(2002)Doi:10.1016/S0968-0896(98)00150-3
(1998)Doi:10.1021/jo981002t
(1998)Doi:10.1016/S0040-4020(98)00857-6
(1998)Doi:10.1016/j.tet.2011.05.044
(2011)Doi:10.1002/jccs.199900008
(1999)
